Literature DB >> 24525314

Ensuring medication adherence with direct oral anticoagulant drugs: lessons from adherence with vitamin K antagonists (VKAs).

Alessandro Di Minno1, Gaia Spadarella2, Antonella Tufano2, Domenico Prisco3, Giovanni Di Minno4.   

Abstract

Medication adherence (taking drugs properly) is uncommon among patients on warfarin. Poor adherence to warfarin leads to an increase in adverse medical events, including stroke in atrial fibrillation (AF). Factors related to patients, physicians and the health system account for poor adherence. Direct oral anticoagulants (DOACs) are easier to use than warfarin, with fewer drug and food interactions and no need for routine blood monitoring. A proper use of DOACs may reduce the risk of stroke in AF. However, in clinical settings where no laboratory monitoring is needed, a poor medication adherence is common and may impact clinical outcomes. In the management of chronic disorders, careful knowledge of the individual patient's attitudes and behaviors is a pre-requisite for a successful doctor-patient communication. To increase patient's awareness of the risks and benefits of DOACs and, in turn, increase medication adherence, at each follow-up visit physicians should screen for priorities and motivational problems; check for the lack of understanding and/or knowledge; assess any health system or personal barriers to medication adherence; identify appropriate interventions and provide tailored support to patient needs. Dissemination of guidelines to the health care chain (prescribing physician, general practitioners, caregivers, nurses, pharmacists) further encourages medication adherence. However, the long-term effect of some of these strategies is unknown; one tool may not fit all patients, and the prescribing physician should consider individualization of these aids to ensure medication adherence and persistence (continuing to take drugs properly in long-term treatments) for DOACs in every day practice.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Communication/cooperation between patients and doctors; Direct oral anticoagulants; Every day practice; Ex vivo laboratory tests; Patient’s awareness; Persistence

Mesh:

Substances:

Year:  2014        PMID: 24525314     DOI: 10.1016/j.thromres.2014.01.016

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  12 in total

1.  The criteria of the Italian Federation of Thrombosis Centres on DOACs: a "real world" application in nonvalvular atrial fibrillation patients already on vitamin K antagonist.

Authors:  Doris Barcellona; Miro Luzza; Nicola Battino; Lara Fenu; Francesco Marongiu
Journal:  Intern Emerg Med       Date:  2014-12-09       Impact factor: 3.397

2.  Medication prescription and adherence disparities in non valvular atrial fibrillation patients: an Italian portrait from the ARAPACIS study.

Authors:  Valeria Raparelli; Marco Proietti; Carmelo Buttà; Paolo Di Giosia; Domenico Sirico; Paolo Gobbi; Salvatore Corrao; Giovanni Davì; Anna Rita Vestri; Francesco Perticone; Gino Roberto Corazza; Francesco Violi; Stefania Basili
Journal:  Intern Emerg Med       Date:  2014-07-03       Impact factor: 3.397

3.  Adherence to oral anticoagulants in patients with atrial fibrillation-a population-based retrospective cohort study linking health information systems in the Valencia region, Spain: a study protocol.

Authors:  G Sanfélix-Gimeno; C L Rodríguez-Bernal; I Hurtado; C Baixáuli-Pérez; J Librero; S Peiró
Journal:  BMJ Open       Date:  2015-10-19       Impact factor: 2.692

Review 4.  Reducing the risk of venous thromboembolism using apixaban - patient perspectives and considerations. Should more attention be given to females?

Authors:  Fabio Fabbian; Alfredo De Giorgi; Ruana Tiseo; Beatrice Zucchi; Roberto Manfredini
Journal:  Patient Prefer Adherence       Date:  2016-01-27       Impact factor: 2.711

5.  Use of direct oral anticoagulants in patients with atrial fibrillation in Scotland: Applying a coherent framework to drug utilisation studies.

Authors:  Tanja Mueller; Samantha Alvarez-Madrazo; Chris Robertson; Marion Bennie
Journal:  Pharmacoepidemiol Drug Saf       Date:  2017-07-28       Impact factor: 2.890

6.  Pharmacists' confidence when providing pharmaceutical care on anticoagulants, a multinational survey.

Authors:  John Papastergiou; Nadir Kheir; Katerina Ladova; Silas Rydant; Fabio De Rango; Sotiris Antoniou; Reka Viola; Maria Dolores Murillo; Stephane Steurbaut; Filipa Alves da Costa
Journal:  Int J Clin Pharm       Date:  2017-11-14

7.  Predictive factors for obtaining a correct therapeutic range using antivitamin K anticoagulants: a tertiary center experience of patient adherence to anticoagulant therapy.

Authors:  Ruxandra Jurcuţ; Sebastian Militaru; Oliviana Geavlete; Nic Drăgotoiu; Sergiu Sipoş; Răzvan Roşulescu; Carmen Ginghină; Ciprian Jurcuţ
Journal:  Patient Prefer Adherence       Date:  2015-09-08       Impact factor: 2.711

8.  Trends in antithrombotic drug use and adherence to non-vitamin K oral anticoagulants in the Netherlands.

Authors:  Susan Hanemaaijer; Fong Sodihardjo; Annemieke Horikx; Michel Wensing; Peter A G M De Smet; Marcel L Bouvy; Martina Teichert
Journal:  Int J Clin Pharm       Date:  2015-08-05

Review 9.  Impact on Drug Safety of Variation in Adherence: The Need for Routinely Reporting Measures of Dose Intensity in Medication Safety Studies Using Electronic Health Data.

Authors:  Elizabeth E Roughead; Nicole L Pratt
Journal:  Drug Saf       Date:  2015-12       Impact factor: 5.606

10.  Associations between illness beliefs, medication beliefs, anticoagulation-related quality of life, and INR control: Insights from the Switching Study.

Authors:  John K Bartoli-Abdou; Jignesh P Patel; Rosa Xie; Olubanke Dzahini; Bipin Vadher; Alison Brown; Lara N Roberts; Raj K Patel; Roopen Arya; Vivian Auyeung
Journal:  Res Pract Thromb Haemost       Date:  2018-06-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.